| 7301 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2017 |
Standard Therapy |
Poland |
70 |
| 7302 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2017 |
Standard Therapy |
Germany |
51 |
| 7303 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2017 |
Standard Therapy |
Germany |
53 |
| 7304 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2017 |
Standard Therapy |
Germany |
68 |
| 7305 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome In Fanconi Anemia |
Hematology |
2017 |
Standard Therapy |
Poland |
23 |
| 7306 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome With Excess Of Blasts |
Hematology |
2017 |
Standard Therapy |
Germany |
62 |
| 7307 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Poland |
63 |
| 7308 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Poland |
63 |
| 7309 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Poland |
66 |
| 7310 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Poland |
62 |
| 7311 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Poland |
55 |
| 7312 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Poland |
62 |
| 7313 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Poland |
62 |
| 7314 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Poland |
72 |
| 7315 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Germany |
70 |
| 7316 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2017 |
Standard Therapy |
Poland |
47 |
| 7317 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2017 |
Standard Therapy |
Poland |
44 |
| 7318 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2017 |
Standard Therapy |
Poland |
56 |
| 7319 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2017 |
Standard Therapy |
Poland |
57 |
| 7320 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2017 |
Standard Therapy |
Poland |
38 |
| 7321 |
Apheresis |
Allogeneic |
Myeloproliferative Neoplasms |
Hematology |
2017 |
Standard Therapy |
Poland |
7 |
| 7322 |
Apheresis |
Allogeneic |
Myeloproliferative Neoplasms |
Hematology |
2017 |
Standard Therapy |
Germany |
37 |
| 7323 |
Apheresis |
Allogeneic |
Niemann–Pick Disease |
Hematology |
2017 |
Standard Therapy |
Poland |
2 |
| 7324 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2017 |
Standard Therapy |
Poland |
36 |
| 7325 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2017 |
Standard Therapy |
Poland |
58 |
| 7326 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2017 |
Standard Therapy |
Poland |
53 |
| 7327 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2017 |
Standard Therapy |
Poland |
1 |
| 7328 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2017 |
Standard Therapy |
Poland |
55 |
| 7329 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
63 |
| 7330 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
56 |
| 7331 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
47 |
| 7332 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
57 |
| 7333 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
65 |
| 7334 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
58 |
| 7335 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
42 |
| 7336 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
36 |
| 7337 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
63 |
| 7338 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
68 |
| 7339 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
52 |
| 7340 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
53 |
| 7341 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
56 |
| 7342 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
65 |
| 7343 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
55 |
| 7344 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
69 |
| 7345 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Poland |
69 |
| 7346 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Germany |
72 |
| 7347 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Germany |
51 |
| 7348 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Germany |
57 |
| 7349 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2017 |
Standard Therapy |
Germany |
52 |
| 7350 |
Apheresis |
Allogeneic |
Osteopetrosis |
Metabolic |
2017 |
Standard Therapy |
Poland |
3 |
| 7351 |
Apheresis |
Allogeneic |
Other Malignancy |
Hematology |
2017 |
Standard Therapy |
Poland |
59 |
| 7352 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Poland |
71 |
| 7353 |
Apheresis |
Allogeneic |
Post–Polycythemia Vera Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Germany |
61 |
| 7354 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2017 |
Standard Therapy |
Germany |
51 |
| 7355 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2017 |
Standard Therapy |
Germany |
66 |
| 7356 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2017 |
Standard Therapy |
Germany |
50 |
| 7357 |
Apheresis |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2017 |
Standard Therapy |
Poland |
4 |
| 7358 |
Apheresis |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2017 |
Standard Therapy |
Poland |
2 |
| 7359 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Poland |
29 |
| 7360 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2017 |
Standard Therapy |
Poland |
32 |
| 7361 |
Apheresis |
Allogeneic |
Prolymphocytic Leukemia |
Hematology |
2017 |
Standard Therapy |
Poland |
38 |
| 7362 |
Apheresis |
Allogeneic |
Prolymphocytic Leukemia |
Hematology |
2017 |
Standard Therapy |
Poland |
63 |
| 7363 |
Apheresis |
Allogeneic |
Richter's Transformation At Chronic Lymphocytic Leukemia |
Hematology |
2017 |
Standard Therapy |
Germany |
60 |
| 7364 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2017 |
Standard Therapy |
Poland |
24 |
| 7365 |
Apheresis |
Allogeneic |
Secondary Myelodysplastic Syndrome |
Hematology |
2017 |
Standard Therapy |
Germany |
61 |
| 7366 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2017 |
Standard Therapy |
Poland |
14 |
| 7367 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2017 |
Standard Therapy |
Poland |
27 |
| 7368 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2017 |
Standard Therapy |
Poland |
32 |
| 7369 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2017 |
Standard Therapy |
Poland |
16 |
| 7370 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2017 |
Standard Therapy |
Poland |
30 |
| 7371 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2017 |
Standard Therapy |
Poland |
7 |
| 7372 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2017 |
Standard Therapy |
Poland |
25 |
| 7373 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2017 |
Standard Therapy |
Poland |
28 |
| 7374 |
Apheresis |
Allogeneic |
T-Cell Lymphoblastic Leukemia |
Hematology |
2017 |
Standard Therapy |
Germany |
24 |
| 7375 |
Apheresis |
Allogeneic |
T-Cell Lymphoblastic Lymphoma |
Hematology |
2017 |
Standard Therapy |
Germany |
19 |
| 7376 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2017 |
Standard Therapy |
Germany |
56 |
| 7377 |
Apheresis |
Autologous |
T-Cell-Lymphoma |
Hematology |
2017 |
Standard Therapy |
Germany |
63 |
| 7378 |
Apheresis |
Allogeneic |
Β – Thalassemia Major |
Hematology |
2017 |
Standard Therapy |
Poland |
4 |
| 7379 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2016 |
Experimental Therapy |
Poland |
22 |
| 7380 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2016 |
Experimental Therapy |
Poland |
32,3 |
| 7381 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2016 |
Experimental Therapy |
Poland |
44,7 |
| 7382 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2016 |
Experimental Therapy |
Poland |
14 |
| 7383 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2016 |
Experimental Therapy |
Poland |
6 |
| 7384 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2016 |
Experimental Therapy |
Poland |
60,5 |
| 7385 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2016 |
Experimental Therapy |
Poland |
3,11 |
| 7386 |
Cord Tissue |
Allogeneic – Unrelated |
Adrenoleukodystrophy |
Neurology |
2016 |
Experimental Therapy |
Poland |
11,11 |
| 7387 |
Cord Tissue |
Allogeneic – Unrelated |
Adrenoleukodystrophy |
Neurology |
2016 |
Experimental Therapy |
Poland |
6,11 |
| 7388 |
Cord Tissue |
Allogeneic – Unrelated |
Adrenoleukodystrophy |
Neurology |
2016 |
Experimental Therapy |
Poland |
9,7 |
| 7389 |
Cord Tissue |
Allogeneic – Unrelated |
Adrenoleukodystrophy; Encephalopathy |
Neurology |
2016 |
Experimental Therapy |
Poland |
8,4 |
| 7390 |
Cord Tissue |
Allogeneic – Unrelated |
Age-Related Macular Degeneration |
Ophthalmology |
2016 |
Experimental Therapy |
Poland |
86,5 |
| 7391 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2016 |
Experimental Therapy |
Poland |
44,5 |
| 7392 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2016 |
Experimental Therapy |
Poland |
60,8 |
| 7393 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2016 |
Experimental Therapy |
Poland |
32,2 |
| 7394 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2016 |
Experimental Therapy |
Poland |
53,7 |
| 7395 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2016 |
Experimental Therapy |
Poland |
59,4 |
| 7396 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2016 |
Experimental Therapy |
Poland |
33,4 |
| 7397 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2016 |
Experimental Therapy |
Poland |
37,4 |
| 7398 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2016 |
Experimental Therapy |
Poland |
39,3 |
| 7399 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2016 |
Experimental Therapy |
Poland |
63,2 |
| 7400 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2016 |
Experimental Therapy |
Poland |
54,11 |